Novo Nordisk's CEO to step down amid market struggle Wegovy and Ozempic-maker Novo Nordisk said today its CEO Lars Fruergaard Jorgensen will step down over concerns the company is losing its first-mover advantage in the highly competitive obesity drug market. Business • 16 May
Novo Nordisk's CEO to step down amid market struggle Wegovy and Ozempic-maker Novo Nordisk said today its CEO Lars Fruergaard Jorgensen will step down over concerns the company is losing its first-mover advantage in the highly competitive obesity drug market. Business • 16 May
Novo Holdings doubles income and returns in 2024 Novo Holdings, the controlling shareholder of obesity drugmaker Novo Nordisk, nearly doubled annual income and investment returns to a record €8 billion in 2024, it said today. Business • 02 Apr
Novo Holdings doubles income and returns in 2024 Novo Holdings, the controlling shareholder of obesity drugmaker Novo Nordisk, nearly doubled annual income and investment returns to a record €8 billion in 2024, it said today. Business • 02 Apr
'Profound vomiting' after Ozempic led to woman's death An inquest in Cork has been told that a 66-year old woman died from "profound vomiting" brought on by the drug Ozempic, which she had been prescribed to help her lose weight. Health • 30 Jan
'Profound vomiting' after Ozempic led to woman's death An inquest in Cork has been told that a 66-year old woman died from "profound vomiting" brought on by the drug Ozempic, which she had been prescribed to help her lose weight. Health • 30 Jan
Profit & weight loss: How Ozempic is disrupting business Ozempic and Wegovy have been shown to have a dramatic impact on users', and their success is up-ending multiple industries too, writes Adam Maguire. Business • 18 Jul 24
Profit & weight loss: How Ozempic is disrupting business Ozempic and Wegovy have been shown to have a dramatic impact on users', and their success is up-ending multiple industries too, writes Adam Maguire. Business • 18 Jul 24
Council seeks new plans from Novo Nordisk on Dublin plant The maker of 'blockbuster' weight loss and diabetes drug, Ozempic, Novo Nordisk has been requested to lodge revised plans for its large scale Dublin plant arising from local residents' concerns. Business • 26 Feb 24
Council seeks new plans from Novo Nordisk on Dublin plant The maker of 'blockbuster' weight loss and diabetes drug, Ozempic, Novo Nordisk has been requested to lodge revised plans for its large scale Dublin plant arising from local residents' concerns. Business • 26 Feb 24
Regulator seizes 254 units of 'falsified' diabetes drug The Health Products Regulatory Authority has said that 254 units of falsified Semaglutide have been detained in Ireland so far this year. Health • 25 Oct 23
Regulator seizes 254 units of 'falsified' diabetes drug The Health Products Regulatory Authority has said that 254 units of falsified Semaglutide have been detained in Ireland so far this year. Health • 25 Oct 23
People hospitalised in Austria over supect fake Ozempic Several people were taken to hospital in Austria after using suspected counterfeits of the diabetes drug Ozempic, according to the federal health safety office. World • 24 Oct 23
People hospitalised in Austria over supect fake Ozempic Several people were taken to hospital in Austria after using suspected counterfeits of the diabetes drug Ozempic, according to the federal health safety office. World • 24 Oct 23
Novo stops Ozempic kidney trial after signs of success Novo Nordisk has said it will stop a trial studying Ozempic to treat kidney failure in diabetes patients ahead of schedule because it was clear from an interim analysis that the treatment would succeed. Business • 11 Oct 23
Novo stops Ozempic kidney trial after signs of success Novo Nordisk has said it will stop a trial studying Ozempic to treat kidney failure in diabetes patients ahead of schedule because it was clear from an interim analysis that the treatment would succeed. Business • 11 Oct 23
Novo Nordisk launches weight-loss drug Wegovy in UK Novo Nordisk has today launched its weight-loss injection Wegovy in Britain, its second debut in Europe in just over a month as the drugmaker seeks to expand in the region even as it struggles to keep up with soaring demand. Business • 04 Sep 23
Novo Nordisk launches weight-loss drug Wegovy in UK Novo Nordisk has today launched its weight-loss injection Wegovy in Britain, its second debut in Europe in just over a month as the drugmaker seeks to expand in the region even as it struggles to keep up with soaring demand. Business • 04 Sep 23
